Compile Data Set for Download or QSAR
Report error Found 32 Enz. Inhib. hit(s) with all data for entry = 6063
TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM47085(US8592454, 71b)
Affinity DataIC50: 0.0270nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106978(US8592454, 176)
Affinity DataIC50: 0.0290nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106983(US8592454, 420)
Affinity DataIC50: 0.0300nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106974(US8592454, 25)
Affinity DataIC50: 0.0310nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106979(US8592454, 192)
Affinity DataIC50: 0.0320nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106982(US8592454, 378)
Affinity DataIC50: 0.0390nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106980(US8592454, 233)
Affinity DataIC50: 0.0490nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106981(US8592454, 308)
Affinity DataIC50: 0.0700nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106977(US8592454, 104)
Affinity DataIC50: 0.0730nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106976(US8592454, 66)
Affinity DataIC50: 0.0750nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106973(US8592454, 4)
Affinity DataIC50: 0.110nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106976(US8592454, 66)
Affinity DataIC50: 2nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106981(US8592454, 308)
Affinity DataIC50: 2.40nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM47085(US8592454, 71b)
Affinity DataIC50: 7.10nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106974(US8592454, 25)
Affinity DataIC50: 7.10nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106978(US8592454, 176)
Affinity DataIC50: 12nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106980(US8592454, 233)
Affinity DataIC50: 42nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106982(US8592454, 378)
Affinity DataIC50: 59nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106983(US8592454, 420)
Affinity DataIC50: 77nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106975(US8592454, 61)
Affinity DataIC50: 99nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106975(US8592454, 61)
Affinity DataIC50: 100nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106977(US8592454, 104)
Affinity DataIC50: 100nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106979(US8592454, 192)
Affinity DataIC50: 120nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106983(US8592454, 420)
Affinity DataIC50: 120nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106976(US8592454, 66)
Affinity DataIC50: 140nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106975(US8592454, 61)
Affinity DataIC50: 290nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106978(US8592454, 176)
Affinity DataIC50: 600nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106982(US8592454, 378)
Affinity DataIC50: 650nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106980(US8592454, 233)
Affinity DataIC50: 1.10E+3nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106974(US8592454, 25)
Affinity DataIC50: 1.40E+3nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106973(US8592454, 4)
Affinity DataIC50: 4.20E+3nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106979(US8592454, 192)
Affinity DataIC50: 4.40E+3nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent